Showing results (11-20 of 111) with videos related to

Sort By:
Pageof 12
Oncotargets and Therapy|September 24, 2016
Next-generation EGFR/HER tyrosine kinase inhibitors for the treatment of patients with non-small-cell lung cancer harboring EGFR mutations: a review of the evidenceXiaochun Wang, David Goldstein, Philip J Crowe, et al.
The Analyst|October 15, 2011
Label-free DNA hybridization detection and single base-mismatch discrimination using CE-ICP-MS assayYan Li, Shao-kai Sun, Jia-lin Yang, et al.
Cancer Investigation|August 17, 2011
IGF1R-targeted therapy and its enhancement of doxorubicin chemosensitivity in human osteosarcoma cell linesFrederick Luk, Yan Yu, William R Walsh, et al.
Anticancer Research|November 5, 2014
Impact of STAT3 inhibition on survival of osteosarcoma cell linesXiaochun Wang, David Goldstein, Philip J Crowe, et al.
Oncology Reports|February 11, 2012
Molecular targeted therapies for cancer: sorafenib mono-therapy and its combination with other therapies (review)Nuha Ibrahim, Yan Yu, William R Walsh, et al.
International Journal of Oncology|April 6, 2018
Antitumour effects and mechanisms of action of the panHER inhibitor, dacomitinib, alone and in combination with the STAT3 inhibitor, S3I-201, in human sarcoma cell linesXiaochun Wang, David Goldstein, Philip J Crowe, et al.
International Journal of Molecular Sciences|May 31, 2017
Significance of Phosphorylated Epidermal Growth Factor Receptor and Its Signal Transducers in Human Soft Tissue SarcomaJia-Lin Yang, Romi Das Gupta, David Goldstein, et al.
Angewandte Chemie (International Ed. in English)|April 2, 2026
Sustainable Aqueous Zn-ion Batteries: Green Materials, Low-Carbon Manufacturing, and Circular EconomyJia-Lin Yang, Miao Du, Jun-Ming Cao, et al.
The Journal of Urology|July 13, 2004
Changes in epidermal growth factor receptor expression in human bladder cancer cell lines following interferon-alpha treatmentXian-Jun Qu, Jia-Lin Yang, Pamela J Russell, et al.
Oncology|September 3, 2005
Interferon-alpha promotes the anti-proliferative effect of gefitinib (ZD 1839) on human colon cancer cell linesJia-Lin Yang, Xian-Jun Qu, Pamela J Russell, et al.
Pageof 12